Pharmafile Logo
Pharmafocus logo
Advanced Search

Novartis

Showing 15 posts of 823 posts found.

Novartis/Incyte’s Jakavi may help fight pancreatic cancer

August 22, 2013
Research and Development, Sales and Marketing Incyte, Jakafi, Novartis, Pancreatic cancer, Xeloda

News
novartis_window

Novartis muscle drug granted ‘breakthrough’ FDA status

August 21, 2013
Research and Development, Sales and Marketing FDA, Novartis, bimagrumab, breakthrough status, sIBM

News
Novartis image

Novartis recognised for efforts in cancer

August 8, 2013
Medical Communications, Sales and Marketing Bush, CEO, Cancer, Novartis

Novartis is the first company to earn a global CEO Cancer Gold Standard accreditation by the non-profit organisation CEO Roundtable …

News
Afinitor image

Late-stage failure for Afinitor

August 8, 2013
Research and Development, Sales and Marketing Afinitor, Cancer, Novartis, liver

Novartis’ oncology programme has received a blow with the news that Afinitor has failed to help patients live longer in …

News

UK rejects meningitis B vaccine Bexsero

July 25, 2013
Sales and Marketing Bexsero, Novartis, Vaccine, meningitis b

The UK government’s department for vaccinations has stunned observers by failing to back the world’s only vaccine for meningitis B. …

News
alexander_triebnigg_panpharma

Panpharma appoints Novartis senior head

July 22, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, celesio AG, panpharma

Pharma trading group Celesio AG has announced that Alexander Triebnigg has taken over the management of the Brazilian pharma wholesaler …

Appointment
Lucentis image

Lucentis and Avastin equal in efficacy

July 19, 2013
Research and Development, Sales and Marketing Lucentis, Novartis, Roche, avastin

Latest results released this morning from a UK government trial show that off-label use of Roche’s Avastin is just as …

News
novartis image

Novartis compound beats Enbrel

July 9, 2013
Sales and Marketing Enbrel, Novartis, Pfizer, skin

One of Novartis’ investigational drugs has beaten Pfizer’s Enbrel in a head-to-head Phase III psoriasis study and is on course …

News
Afinitor iimage

Novartis’ Afinitor fails NICE test

July 8, 2013
Sales and Marketing Afinitor, NHS, NICE, Novartis

Novartis’ breast cancer drug Afinitor (everolimus) has been knocked back by NICE as “it is not good value for money”. …

News

Heart failure treatment given Breakthrough Status

June 27, 2013
Sales and Marketing Breakthrough Therapy Designation, Novartis, RLX03O, serelaxin

Novartis’ new treatment for heart failure has been granted Breakthrough Therapy designation status by the FDA. RLX030 (serelaxin) is for …

News

Novartis works in MS switch

June 11, 2013
Research and Development, Sales and Marketing MS, Novartis, gilenya

Novartis’ oral MS drug Gilenya has been found to help multiple sclerosis (MS) patients who switch to it after taking …

News
Novartis image

Novartis receives FDA warning

June 6, 2013
Manufacturing and Production, Sales and Marketing CGMP, FDA, GMP, Novartis

The FDA has castigated Novartis for what it calls ‘significant violations’ of current good manufacturing practice (CGMP) regulations for finished …

News

Novartis drug shows cancer promise

June 5, 2013
Research and Development, Sales and Marketing ASCO, Cancer, Novartis

A Novartis drug which has been given breakthrough therapy designation by the FDA has demonstrated early promise in patients with …

News

Promising signs for Novartis’ lung cancer drug

June 4, 2013
Sales and Marketing ALK+, ASCO, LDK378, NSCLC, Novartis

Targeted lung cancer treatment LDK378 has been shown to help patients with the ALK+ gene mutation in a phase I trial.Novartis’ drug …

News
Novartis image

Diovan trials may have been run by Novartis staff

May 29, 2013
Research and Development, Sales and Marketing Diovan, Novartis

Several post-marketing clinical trials of the blockbuster blood pressure drug Diovan may have been run by employees of the drug’s …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026